Rallybio's chart data is dated 2026-10-08. Recorded technical signals: Near 52-week high, VCP. There are 11 published signal records.
Rallybio last closed at $16.99 (+0.35%) on 2026-10-08. Signals today: Near 52-week high, VCP. Listed on Nasdaq. Trailing 12 months PER is 2.2×. Its overall grade ranks 183 of 738 stocks in Healthcare.
About this company
Rallybio last closed at $16.99 (+0.35%) on 2026-10-08. Signals today: Near 52-week high, VCP. Listed on Nasdaq.
Details →Reported results
Position in sector
Healthcare · Overall A- · 183/738
Valuation grade D
Related stocks
- RegeneronCompetitor
이식·희귀질환 항체/바이오 치료제 파이프라인에서 경쟁 가능성이 큼
- Alexion PharmaceuticalsCompetitor
희귀질환 치료제 시장의 대표 강자이며 보체계열 타깃에서 경쟁
- Apellis PharmaceuticalsCompetitor
보체(complement) 기반 희귀질환 치료제 개발로 유사한 경쟁 구도
About Rallybio
- What technical signals does Rallybio (RLYB) have?
- Rallybio current technical signals: Near 52-week high, VCP.
- Is Rallybio a cup-and-handle pattern?
- No. Rallybio has no valid Cup signal right now.
- What published figures are available for Rallybio?
- Market cap: $89.69M. Trailing 12 months PER: 2.2×. Latest quarter PBR: 1.04×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Major stocks in the same sector
2026-10-09 dataset
Turn what you saw on this name into a strategy
Ask Q about Rallybio, or open the plan table on the main site.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.